Post

Bayer wins FDA breakthrough therapy designation for NSCLC candidate

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bayer for its non-small cell lung cancer …

UK’s adsilico raises $4.4m to develop virtual trial solution

UK University of Leeds spinout adsilico has raised £3.5m ($4.4m) in seed funding to develop an in-silico trial solution. The company …

Streamlining supply chain operations in focus at Clinical Trial Supply Europe 2024 

How can true supply chain agility be achieved in response to increasingly complex trial demands?  This question will be explored at …

Sanofi looks to advance CSU drug rilzabrutinib in Phase III trial

Sanofi shared positive results from the Phase II trial of rilzabrutinib in patients with moderate to severe chronic spontaneous urticaria …

PCM Trials acquires EmVenio to boost decentralised clinical trials

PCM Trials has acquired US-based EmVenio Research, a community-based clinical trial site provider equipped with mobile research units, to design …